73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

byAmerican Society for Radiation OncologyStereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long

Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

byAmerican Society for Radiation OncologyStereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long
'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainDespite some confusing messages this week around the value of colonoscopies, Wilmot Cancer Institute physici

'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainDespite some confusing messages this week around the value of colonoscopies, Wilmot Cancer Institute physici
Body's natural signal carriers can help melanoma spread

Body's natural signal carriers can help melanoma spread

byUniversity of Eastern FinlandThe image shows a dividing melanoma cell with its hedgehog-like spikes. The cell is also secreting vesicles. Image credit: Kirsi RillaA new study from Finland shed

Body's natural signal carriers can help melanoma spread

byUniversity of Eastern FinlandThe image shows a dividing melanoma cell with its hedgehog-like spikes. The cell is also secreting vesicles. Image credit: Kirsi RillaA new study from Finland shed
'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

by Paul Workman,Institute of Cancer ResearchAbiraterone was the first treatment shown to be effective in men with advanced prostate cancer. Credit: Institute of Cancer ResearchCancer was in the

'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

by Paul Workman,Institute of Cancer ResearchAbiraterone was the first treatment shown to be effective in men with advanced prostate cancer. Credit: Institute of Cancer ResearchCancer was in the
Hope for new therapy to stop advanced skin cancer

Hope for new therapy to stop advanced skin cancer

bySt. George's University of LondonMorphological effects of P16P1 observed for melanoma cells but not fibroblasts. Representative phase-contrast images of cells after 5 days of growth with o

Hope for new therapy to stop advanced skin cancer

bySt. George's University of LondonMorphological effects of P16P1 observed for melanoma cells but not fibroblasts. Representative phase-contrast images of cells after 5 days of growth with o
Scientists describe how iron helps drive tumor development in colorectal cancer

Scientists describe how iron helps drive tumor development in colorectal cancer

by Michael Haederle,University of New MexicoTFRC is increased in human CRC and is positively correlated with the CTNNB1 protein expression. Detection of TFRC expression in human normal (n = 5–8)

Scientists describe how iron helps drive tumor development in colorectal cancer

by Michael Haederle,University of New MexicoTFRC is increased in human CRC and is positively correlated with the CTNNB1 protein expression. Detection of TFRC expression in human normal (n = 5–8)
Faulty DNA repair may lead to BRCA-linked cancers

Faulty DNA repair may lead to BRCA-linked cancers

byWeill Cornell Medical CollegeStalled replication forks (yellow arrows) are detected at the BRCA1 gene in cells containing a BRCA1 germline mutation. Credit: Weill Cornell MedicineError-prone D

Faulty DNA repair may lead to BRCA-linked cancers

byWeill Cornell Medical CollegeStalled replication forks (yellow arrows) are detected at the BRCA1 gene in cells containing a BRCA1 germline mutation. Credit: Weill Cornell MedicineError-prone D
Protein partnership effectively fends off pancreatic cancer progression

Protein partnership effectively fends off pancreatic cancer progression

byVirginia Commonwealth UniversityModel for the functional interaction between Smad4 and Prdm16 during PDAC formation and progression. Credit:Journal of Cell Biology(2023). DOI: 10.1

Protein partnership effectively fends off pancreatic cancer progression

byVirginia Commonwealth UniversityModel for the functional interaction between Smad4 and Prdm16 during PDAC formation and progression. Credit:Journal of Cell Biology(2023). DOI: 10.1
A feasibility study for salvage radiation therapy in prostate cancer

A feasibility study for salvage radiation therapy in prostate cancer

by Impact Journals LLCCredit: CC0 Public DomainAn editorial paper waspublishedinOncoscienceon May 20, 2024, titled, "Deep learning-assisted lesion segmentation in PET/CT i

A feasibility study for salvage radiation therapy in prostate cancer

by Impact Journals LLCCredit: CC0 Public DomainAn editorial paper waspublishedinOncoscienceon May 20, 2024, titled, "Deep learning-assisted lesion segmentation in PET/CT i
CRISPR-Cas9 datasets analysis leads to largest genetic screen resource for cancer research

CRISPR-Cas9 datasets analysis leads to largest genetic screen resource for cancer research

byWellcome Trust Sanger InstituteCredit: CC0 Public DomainA comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 g

CRISPR-Cas9 datasets analysis leads to largest genetic screen resource for cancer research

byWellcome Trust Sanger InstituteCredit: CC0 Public DomainA comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 g